PEAK6 Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
PEAK6 Group's BIIB Position: Q2 2018 in Review
PEAK6 Group sold out of Biogen (BIIB) in Q2 2018, closing a stake of 24,081 shares — an estimated $6.77M sold.
PEAK6 Group first reported a position in BIIB in Q2 2013 and held it in 17 quarters. The position peaked at $34M in Q4 2014. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.
- PEAK6 Group reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
- PEAK6 Group sold 24,081 Biogen shares in Q2 2018, an estimated $6.77M.
- PEAK6 Group first reported a position in Biogen in Q2 2013 and held it in 17 quarters.
- PEAK6 Group's Biogen position peaked at $34M in Q4 2014.
- 1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.
Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.